Similar articles

• [Production of leukocidin of Pseudomonas aeruginosa strains isolated from patients and environmental specimens].

  Sibata M, Kazuyama Y, Yamamoto M, Kubota Y, Matsuura M, Homma Y, Hirayama T, Kato I. Sibata M, et al. Kansenshogaku Zasshi. 1985 Jan;59(1):14-8. doi: 10.11150/kansenshogakuzasshi1970.59.14. Kansenshogaku Zasshi. 1985. PMID: 3923132 Japanese. No abstract available.
• Protease and elastase production in relation to serotype of Pseudomonas aeruginosa.

  Iida T, Katoh M, Tsukiyama F, Nakamura K, Watanabe T, Ikeda M, Muroki K, Fujiue Y, Kuwabara M. Iida T, et al. Hiroshima J Med Sci. 1982 Sep;31(3):181-5. Hiroshima J Med Sci. 1982. PMID: 6816762 No abstract available.
• Protease & elastase production & their association with aeruginocine & pigment production by clinical isolates of Pseudomonas aeruginosa.

  Kapur R, Shriniwas. Kapur R, et al. Indian J Med Res. 1987 Jan;85:10-3. Indian J Med Res. 1987. PMID: 3108152 No abstract available.
• Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.

  Homma JY. Homma JY. Jpn J Exp Med. 1980 Jun;50(3):149-65. Jpn J Exp Med. 1980. PMID: 6776324 Review. No abstract available.
• [Evaluation of multiple Pseudomonas aeruginosa strains with different characteristics in clinical specimens; combined results from serotyping, drug susceptibility and enzyme production].

  Nakasone I, Kusano N, Hokama S. Nakasone I, et al. Rinsho Byori. 1995 Nov;43(11):1135-9. Rinsho Byori. 1995. PMID: 8551677 Review. Japanese.